Search
Blogs
Read more and be inspired by the Center's collection of researchers and ecosystem experts from throughout the world.
Crowdsourcing to better forecast drug approvals
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
Legatum Foundry Fellowship for entrepreneurs in Africa launches
By
Fellowship applications open on May 3, 2021 for entrepreneurs working and living in Ethiopia, Ghana, Nigeria, Kenya, Rwanda, Senegal, and Uganda.
How Nobel laureate Maria Ressa pivoted under pressure
By
Maria Ressa built a successful media startup — and exposed human rights issues — while fighting disinformation and attacks from the Philippine government.
Growing importance of academia in accelerating biomedical innovation
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
Gamification techniques to improve online teaching and learning
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
MIT Sloan and King’s College London host summit on healthcare systems
By
“Building Sustainable Healthcare Systems through Innovation and Entrepreneurship” will bring together entrepreneurs, academics, healthcare professionals and policymakers from around the world.